Panelists:

Christian T. Ruff, MD, MPH
Associate Professor of Medicine, Harvard Medical School; Director of General Cardiology, Brigham and Women’s Hospital; Senior Investigator, TIMI Study Group, Boston, Massachusetts

C. Michael Gibson, MS, MD
Professor of Medicine, Harvard Medical School; Interventional Cardiologist, Beth Israel Deaconess Medical Center; CEO, Nonprofit Baim Institute for Clinical Research, Boston, Massachusetts

Siddharth Patel, MD
Investigator at TIMI Study Group
Cardiologist at Brigham and Women’s Hospital

Disclaimer: All video and audio content is copyrighted and remains the property of clinicaltrialresults.org. Video and audio content permission has been provided by Dr. C. Michael Gibson. Authors of slides retain copyright of their slides.

Accreditation:

Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.

Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio.

Christian T. Ruff, MD, MPH
Director, General Cardiology, Brigham and Women’s Hospital; Senior Investigator, TIMI Study Group; Associate Member, Broad Institute of MIT and Harvard; Associate Professor of Medicine, Harvard Medical School

Disclaimer: All video and audio content is copyrighted and remains the property of clinicaltrialresults.org. Video and audio content permission has been provided by Dr. C. Michael Gibson. Authors of slides retain copyright of their slides.

Addressing Suboptimal Anticoagulation in Atrial Fibrillation: Uncoupling the Potential of Factor XI/XIa Inhibition for Stroke Prevention

Credit: 0.5 AMA PRA Category 1 Credit™, 0.5 ANCC contact hours, 0.5 ACPE contact hours, and ABIM MOC contact hours

Moderator:

Marc S. Sabatine, MD, MPH
Chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study Group, the Lewis Dexter, MD, Distinguished Chair in Cardiovascular Medicine at Brigham and Women’s Hospital (BWH), and a Professor of Medicine at Harvard Medical School (HMS).

Panelists:

Christian T. Ruff, MD, MPH
Director, General Cardiology, Brigham and Women’s Hospital; Senior Investigator, TIMI Study Group; Associate Member, Broad Institute of MIT and Harvard; Associate Professor of Medicine, Harvard Medical School

Jeffrey I. Weitz, MD, FRCPC, FRSC, FACP, FCCP
Professor of Medicine and Biochemistry and Biomedical Sciences, McMaster University, Executive Director, Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada

Evaluating Evolving Approaches to Treating Thrombosis in Cancer: From Concept to Clinic

Faculty:

Jean M. Connors, MD
Medical Director, Hemostatic Antithrombotic Stewardship
Medical Director, Anticoagulation Management Services (Hematology Division), Brigham and Women’s Hospital/Dana-Farber Cancer Institute; Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts, United States

Alok A. Khorana, MD
Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University; Sondra and Stephen Hardis Chair in Oncology Research; Vice Chair, Clinical Services; Director, GI Malignancies Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States

Jeffrey I. Weitz, MD, FRCPC, FRSC, FACP, FCCP
Professor of Medicine and Biochemistry and Biomedical Sciences, McMaster University, Executive Director, Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada